Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corium Intl (CORI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Corium to Present at Upcoming Healthcare Conferences

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 10.85 (+0.18%)
Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole

VANCOUVER, BC--(Marketwired - August 24, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing,...

AQS.VN : 0.195 (-2.50%)
AQSZF : 0.1631 (-0.61%)
CORI : 10.85 (+0.18%)
Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole

VANCOUVER, BC--(Marketwired - August 24, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing,...

AQS.VN : 0.195 (-2.50%)
AQSZF : 0.1631 (-0.61%)
CORI : 10.85 (+0.18%)
Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the third quarter ended June 30, 2017 on Thursday, August 3, 2017 after the close of the U.S. financial...

CORI : 10.85 (+0.18%)
Corium International (CORI) Catches Eye: Stock Jumps 11.9%

Corium International, Inc. (CORI) moved big last session, as the company saw its shares rise almost 12% on the day.

AQXP : 13.75 (+0.88%)
CORI : 10.85 (+0.18%)
Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex(TM) Donepezil Transdermal System at Alzheimer's Association International Conference(R) 2017

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 10.85 (+0.18%)
Corium Joins Russell 3000(R) Index

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 10.85 (+0.18%)
Corium to Present at the Jefferies 2017 Global Healthcare Conference

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 10.85 (+0.18%)
Amphastar (AMPH) in Focus: Stock Moves 9.7% Higher

Amphastar Pharmaceuticals (AMPH) was a big mover last session, as the company saw its shares rise almost 10% on the day.

AMPH : 16.10 (-1.83%)
CORI : 10.85 (+0.18%)
Corium Prices Follow-On Offering of Common Stock

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the...

CORI : 10.85 (+0.18%)
AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session

AxoGen, Inc. (AXGN) shares rose a little above 6% in the last trading session.

AXGN : 18.60 (-0.27%)
CORI : 10.85 (+0.18%)
Can The Uptrend Continue for Corium International (CORI)?

Investors certainly have to be happy with Corium International Inc (CORI) and its short term performance

CORI : 10.85 (+0.18%)
Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today reported preliminary...

CORI : 10.85 (+0.18%)
Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited...

CORI : 10.85 (+0.18%)
Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View

Shire plc (SHPG) reported first-quarter 2017 earnings of $3.63 per American Depositary Share (ADS), beating the Zacks Consensus Estimate of $3.22 and up 13.8% from the year-ago quarter figure of $3.19....

SHPG : 155.09 (-0.17%)
INFI : 1.14 (-1.72%)
NVLS : 2.40 (+2.13%)
CORI : 10.85 (+0.18%)
Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards?

We expect Anthem Inc. (ANTM) to beat expectations when it reports first-quarter 2017 results on Apr 26, before the market opens.

BDX : 193.06 (+0.78%)
ANTM : 182.86 (-0.35%)
CORI : 10.85 (+0.18%)
ALGN : 188.00 (+0.90%)
Aimmune Therapeutics Appoints Eric Bjerkholt as Chief Financial Officer

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), today announced the appointment of Eric Bjerkholt as Chief Financial Officer.

AIMT : 23.62 (-1.17%)
JPM : 94.83 (-0.21%)
CORI : 10.85 (+0.18%)
Corium to Present at the 16th Annual Needham Healthcare Conference

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 10.85 (+0.18%)
Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that...

CORI : 10.85 (+0.18%)
Corium Reports Positive Progress in Pilot Bioequivalence Study of Once-Weekly Corplex(TM) Donepezil Patch

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today reported on...

CORI : 10.85 (+0.18%)

Van Meerten Stock Picks

5 Great Mid Caps
Today I wanted to find 5 Mid Cap stocks that had a high gain over the last year and continue to have current momentum.
DAN +0.41 , IPGP +4.16 , TEX -0.46 , NVR +29.06 , TTWO +1.12
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 -0.14% ) this morning are down -0.09% on heightened North Korean tensions after North Korean President Kim Jong Un promised the "highest level of hardline" countermeasures against the U.S.... Read More

Chart of the Day

Chart of the Day

Fiat Chrysler Automobiles (FCAU) is the Barchart Chart of the Day.  The international auto producer has a Trend Spotter buy signal, a Weighted Alpha of 190.70+ and gained 174.92% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures settled Friday with 2 to 3 1/2 cent gains, as Dec was 1 1/4 cent lower on the week. Rains over the next week could slow corn harvest in most of the WCB. Next Friday at 11:00 a.m. will be the release of the Sept 1 Grain Stocks report. The...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.